Back to dashboard
MedicaidBilling CodesMedium impact

Pharmacy Billing of Subcutaneous Monoclonal Antibody Treatment

Illinois Medicaid - HFS·IL · Pharmacy, Infectious Disease·Provider Notice
Effective date
Nov 1, 2021
We identified it
Jun 20, 2026
Days to comply

Summary

Illinois pharmacies can now bill Medicaid for administering subcutaneous monoclonal antibody treatment (REGEN-COV) to COVID-19 positive patients, with incentive fees of $750 for home administration and $450 for pharmacy administration. Claims must be submitted via NCPDP with specific field requirements including zero ingredient cost and appropriate professional service codes.

Action Required

Action needed
Illinois pharmacies only: Update NCPDP billing system to submit REGEN-COV claims with Basis of Cost Determination '15', Ingredient Cost $0.00, Professional Service Code 'MA', Days Supply '1', and appropriate incentive amount ($450 or $750) in field 438-E3. Ensure proper documentation is maintained for all administrations.